SCHEMBL2988193

SCHEMBL2988193

O=[N+]([O-])c1cc(Br)cc(-c2ncccn2)c1-c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S100A4 P26447 1/20 0.46
▸ TRPV1 Q8NER1 1/20 0.46
▸ MAPT P10636 10/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ GRM5 P41594 2/20 0.41
▸ PLCG2 P16885 1/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ GPR35 Q9HC97 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ GALR2 O43603 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MPI P34949 1/20 0.38
▸ CCR6 P51684 1/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6916314 0.83 S100A4 (0.46) S100A4TRPV1MAPTALDH1A1SMN1; SMN2
SCHEMBL13813006 0.82 CTSB (0.47) S100A4TRPV1MAPTNPC1RAB9A
SCHEMBL29430825 0.78 S100A4 (0.46) S100A4TRPV1MAPTNPC1RAB9A
SCHEMBL22636651 0.78 S100A4 (0.46) S100A4TRPV1MAPTNPC1RAB9A
SCHEMBL1359386 0.78 ALDH1A1 (0.43) S100A4TRPV1MAPTMEN1KMT2A
SCHEMBL6916316 0.75 KMT2A (0.53) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL4150422 0.72 PDE10A (0.53) S100A4MAPTNPC1RAB9AMEN1
SCHEMBL30117516 0.72 PDE10A (0.53) S100A4MAPTNPC1RAB9AMEN1
SCHEMBL28697427 0.71 MEN1 (0.42) MAPTNPC1RAB9AGRM5MEN1
SCHEMBL444702 0.71 ALDH1A1 (0.53) S100A4MAPTNPC1RAB9AGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229379-A2 SOLID FORMS OF 1-ETHYL-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZOL-2-YL)UREA Vertex Pharmaceuticals Incorporated (US) 2010-09-22 — — EP disclosed
WO-2009076200-A2 SOLID FORMS OF 1-ETHYL-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZOL-2-YL)UREA VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-06-18 — — WO disclosed
Send feedback